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Tet(X4) in A. caviae, a potential reservoir for the dissemination of
tigecycline resistance into different environmental niches. The
tet(X4)-carrying element analysis suggests that the catD-tet(X4)-
ISCR2 gene cassette is highly active and may further spread into
different bacterial species. Continuous monitoring of tet(X4) in
humans, animals and environments should be considered, to im-
prove understanding and address the spread of resistance to tet-
racyclines, including tigecycline.
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Sir,
Fosfomycin is increasingly used to treat infections caused by MDR
bacteria.1 Fosfomycin acts by inhibiting UDP-N-acetylglucosamine
enolpyruvyl transferase (murA), which prevents the formation of N-
acetylmuramic acid, an essential component of peptidoglycan.1
Although resistance to fosfomycin is still low in Escherichia coli, the
acquisition of fosA may reduce future activity of fosfomycin to treat
infections caused by E. coli.2 FosA is a glutathione transferase that
inactivates fosfomycin through catalysing the addition of glutathi-
one. fosA genes are often present in the chromosome of Klebsiella
pneumoniae, but not in the chromosome of E. coli.2,3 Klebsiella varii-
cola is closely related and often misidentified as K. pneumoniae.4
While horizontal spread of fosA has been demonstrated in vitro,5
we here provide evidence for in vivo fosA transmission from K. varii-
cola to E. coli, resulting in development of fosfomycin resistance.
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The Medical Research Ethics Committee of the University
Medical Center Utrecht confirmed that the Medical Research
Involving Human Subjects Act does not apply to this study (refer-
ence number WAG/mb/18/027282). We were not able to obtain in-
formed consent because the patient died a few years ago. All
information including gender, age, dates and medical history that
was not directly clinically relevant has been omitted to protect the
privacy of the patient.
An aged patient had a suspicion of chronic endovascular infection
of their aortic bifurcation graft, which the patient received after an
acute aortic aneurysm 22 years earlier. The patient had suffered from
recurrent episodes of sepsis, with blood cultures yielding
Propionibacterium spp., K. variicola, Citrobacter koseri and
Pseudomonas aeruginosa, as determined by MALDI-TOF MS. Positron
emission tomography (PET)-CT findings were compatible with pros-
thetic graft infection. The patient subsequently developed septic
shock with E. coli bacteraemia without a clear source of infection that
was treated successfully with intravenous ceftriaxone. The isolate
was resistant to amoxicillin/clavulanic acid and ciprofloxacin that had
been used to suppress chronic infection, prompting the addition of
oral fosfomycin at 3 g every 48 h. Seven months later, while still using
fosfomycin, the patient developed spondylodiscitis. Blood cultures
drawn at the time isolated E. coli with an identical resistance pattern,
except being resistant to fosfomycin. Fosfomycin was discontinued
and the patient received a prolonged course of ceftriaxone.
Fosfomycin susceptibility, determined by agar dilution accord-
ing to CSLI guidelines,6 demonstrated a rise in the MIC from 2 mg/L
for the initial E. coli isolate to.1024 mg/L for the second E. coli iso-
late. WGS revealed five SNP differences between E. coli isolates in
the core genome, based on core genome MLST (cgMLST) analysis.7
Yet, the second E. coli isolate has a 3573 bp insertion consisting of
ISEcp1, a fosA gene we named fosA9 as the next available number
according to NCBI, syrM1 and lysN2. The insertion is flanked by 5 bp
DRs (AAAAA) suggesting mobilization of this fosA9 gene cluster by
ISEcp1 (Figure 1).8 Genes other than fosA9 responsible for fosfomy-
cin resistance were not found. At the time of the first E. coli sepsis
episode, six K. variicola had been isolated from rectum swabs and
blood cultures over a period of 20 months (Table S1, available as
Supplementary data at JAC Online). cgMLST analysis revealed a
maximum of 16 SNP differences between K. variicola isolates.7 The
same cluster as above containing fosA9, without the mobile ge-
netic element ISEcp1, was identified in the K. variicola isolates, sug-
gesting K. variicola to be the source of fosA9 acquired by E. coli
(Figure 1). fosA genes were not identified in other clinical isolates
from this patient. Sequence information of all isolates has been de-
posited in the European Nucleotide Archive (ENA) under project
number PRJEB32329.
fosA transfer from Klebsiella spp. to E. coli, leading to fosfo-
mycin resistance, has been demonstrated in vitro.3 Based on
publicly available genomes, fosA and adjacent genes are well
conserved in K. variicola (minimum 98% identity to fosA9) and K.
pneumoniae (minimum 94% identity to fosA9) isolates.
According to mlplasmids, PlasmidFinder and contig coverage,
fosA9 was predicted to be located in the chromosome of the
second E. coli and all K. variicola isolates.9,10 However, based on
BLASTn, the contig containing fosA9 aligns to plasmid sequen-
ces. The localization of fosA9 in E. coli can thus only be con-
firmed by completely assembling its genome using long-read
sequencing, as the mobilization of the fosA9 gene cluster by an
IS element might switch its genomic background. We postulate
that fosA9 transfer from K. variicola to E. coli occurred in the gas-
trointestinal tract, as K. variicola was not co-cultured in the
blood at the time of E. coli bacteraemia. We hypothesize that
fosfomycin pressure played a role in this transfer; however, this
Figure 1. Schematic representation of the contig (ECO-BAB-IMI-103297_P-ACH-BAB-IMI-103242_1528359160_131_length_8653_cov_18.1163
_ID_8928, 8653 bp) in the fosfomycin-resistant E. coli isolate containing a fosA9 gene cluster originating from a K. variicola isolate. The
ISEcp1-syrM1-fosA9-lysN2 region is flanked by 5 bp DRs (AAAAA), suggesting mobilization from K. variicola by ISEcp1. Upstream and downstream
sequences of the insertion region align to contig ECO-BAB-IMI-103298_P-ACH-BAB-IMI-103242_1528359160_92_length_16411_cov_29.2905
_ID_8090 from the first susceptible E. coli isolate. Sequence information of complete genomes of all isolates and separate sequences of the relevant
contigs (containing fosA9 in E. coli and K. variicola, and ECO-BAB-IMI-103298_P-ACH-BAB-IMI-103242_1528359160_92_length_16411_cov_29.2905
_ID_8090 from the susceptible E. coli) have been deposited in the ENA under project number PRJEB32329. This figure appears in colour in the online
version of JAC and in black and white in the print version of JAC.
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has to be confirmed with further experiments in vitro.
Acquisition of fosA9 was associated with an 8-fold increase in
the MIC for E. coli (from 2 to 1024 mg/L) while, despite the pres-
ence of fosA9 in the chromosome of the K. variicola isolates, the
fosfomycin MICs were below the EUCAST susceptibility break-
point of 32 mg/L (Table S1).6 This could suggest either higher
dependency of E. coli growth on glutathione or a difference in
fosA9 expression or metabolism, i.e. higher expression by the
ISEcp1 promoter present upstream of the fosA9 gene cluster.8
In conclusion, our case illustrates the potential of long-term
use of oral fosfomycin to promote horizontal gene transfer of
fosA9 from commensal gut flora to potential pathogenic microor-
ganisms, such as E. coli.
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Sir,
Carbapenem-resistant Enterobacteriaceae (CRE) have been
globally reported, not only in hospitals, but also in the community,
animals (including livestock, companion animals and wildlife), the
environment and food,1,2 and they are recognized as a serious
threat to human health. Recently, an increased prevalence of
Escherichia coli strains carrying blaNDM from food in China from
2015 to 2018 has been reported, highlighting the risk of human
exposure to food polluted by strains producing NDM carbapene-
mase.3,4 OXA-48-producing CRE have been frequently reported
in Europe and have been identified in many ecosystems.
However, Enterobacteriaceae producing OXA-48 had so far
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